Search for:
Category

Post M&A Disputes

Category

In Western Pharmacy (“Claimant”) v. Park Medical et al. (“Respondents”), the Tribunal issued the final award on 28 March 2022 in Claimant’s favour. The Tribunal held that Respondents – the sellers of a chain of pharmacies – committed a negligent misrepresentation towards the Claimant – the purchaser. The Tribunal calculated the damages using the same EBITDA multiple that Claimant used to calculate the purchase price for the pharmacies. The dispute was governed by California law.…